Aunque los probiticos generalmente se consideran seguros para la mayora de las personas sanas, pueden producir efectos adversos y existen situaciones clnicas donde su uso requiere precaucin especial o est contraindicado
A landmark JAMA Internal Medicine meta-analysis of 76 randomized clinical trials found that GLP-1 receptor agonists as a class were associated with increased risks of cholelithiasis (relative risk 1.27), cholecystitis (relative risk 1.36), and biliary disease broadly (relative risk 1.55)
Patients with prediabetes, type 2 diabetes, or significant weight loss goals should consult a qualified healthcare provider to evaluate whether prescription GLP-1 therapy, lifestyle modifications, or precision diagnostics (like genetic testing) are more appropriate
Our clinicians can find the right medication for you, prescribe it if needed, and help you reach your goals
This is that protein burns more calories to digest than the other macronutrients
Instead, it enables your provider to personalize your dose, timing, and complementary protocols for your fastest safe results based on your genetic profile